Upregulation of AXL and β-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance

• Sutapa Sinha,
• Charla R. Secreto,
• Justin C. Boysen,
• Connie Lesnick,
• Zhiquan Wang,
• Wei Ding,
• Timothy G. Call,
• Saad J. Kenderian,
• Sameer A. Parikh,
• Steven L. Warner,
• David J. Bearss,
• Asish K. Ghosh,
• Neil E. Kay

Affiliations

Sutapa Sinha

Division of Hematology, Mayo Clinic

Charla R. Secreto

Division of Hematology, Mayo Clinic

Justin C. Boysen

Division of Hematology, Mayo Clinic

Connie Lesnick

Division of Hematology, Mayo Clinic

Zhiquan Wang

Division of Hematology, Mayo Clinic

Wei Ding

Division of Hematology, Mayo Clinic

Timothy G. Call

Division of Hematology, Mayo Clinic

Saad J. Kenderian

Division of Hematology, Mayo Clinic

Sameer A. Parikh

Division of Hematology, Mayo Clinic

Steven L. Warner

Tolero Pharmaceuticals, Inc.

David J. Bearss

Tolero Pharmaceuticals, Inc.

Asish K. Ghosh

Stephenson Cancer Center and Department of Pathology, The University of Oklahoma Health Sciences Center

Neil E. Kay

Division of Hematology, Mayo Clinic